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Abstract 
Background & Aims 
Cirrhosis due to alcohol could be avoided if drinking behaviour could be altered earlier in the 
disease course. Our aim was to quantify the burden of morbidities in patients prior to 
alcoholic cirrhosis diagnosis, as this may inform the earlier identification of people at high 
risk for targeted interventions. 
Methods 
We carried out a case-control study using 2,479 incident cases of alcoholic cirrhosis and 
24,790 controls identified from 357 primary and secondary care centres in England. We 
assessed the prevalence of morbidities that are partly attributable to alcohol (namely 
malignant neoplasms, diabetes, epilepsy, injuries, cardiovascular and digestive diseases) prior 
to alcoholic cirrhosis diagnosis. We compared prevalence in cases to the control population 
and used logistic regression to derive odds-ratios (95% CI). 
Results 
58% of cases compared to 29% of controls had had at least one alcohol-attributable condition 
before cirrhosis diagnosis. The most frequent conditions (proportion in cases versus controls) 
were intentional injuries(35.9% versus 11.9%) and cardiovascular diseases(23.2% 
versus15.6%), followed by diabetes(12.8% versus 5.3%), digestive diseases(6.1% versus 
1.2%) and epilepsy(5.0% versus 1.1%). The strongest association with alcoholic cirrhosis 
was found for digestive diseases(OR 5.4 [4.4-6.7]), epilepsy(OR4.4[3.5-5.5]) and injuries 
(OR 4.0[3.7-4.4]) particularly among those aged 18-44years.  
Conclusion 
These data highlight the high burden of other alcohol-attributable conditions in patients prior 
to alcoholic cirrhosis diagnosis. Reviewing those consistently presenting with any of these 
conditions more closely could help practitioners reduce/avoid the long term consequences of 
development of alcoholic liver disease.  
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Key points 
 Early identification of people at risk of alcoholic cirrhosis could help limit/reverse 
the increasing rates of liver disease mortality in the UK.  
 We found a high burden of other alcohol-attributable conditions (injuries, 
seizures, diabetes, cardiovascular and digestive diseases) in patients up to 
10years prior to the diagnosis of alcoholic cirrhosis. 
 Injuries, seizures and digestive diseases had the strongest association with 
subsequent development of alcoholic cirrhosis. 
 Physicians could combine these early warning signs of alcohol-related 
attendances with other important prognostic information to increase their 
assessment of alcohol misuse and liver disease risk in individuals. 
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Introduction 
Alcoholic cirrhosis is one of the major contributors to liver disease morbidity and 
mortality(1,2). With some variation, it requires around 10-20 years to become fully 
established(3,4). During this time people are likely to be drinking alcohol heavily(4–7) and 
therefore likely to present to their family doctor/General Practitioner or to hospital emergency 
departments for conditions that are related to alcohol, but not necessarily directly related to 
cirrhosis. This is not dissimilar to the situation where patients persistently present to primary 
care with smoking related symptoms e.g. weight loss and angina-like chest pain several years 
before they are diagnosed with lung cancer(8–10).  Knowledge of such symptoms that are 
associated with the cause of a disease, rather than a disease itself, has been used in the past as 
a proxy for risk stratification of individuals for targeted interventions(11,12). Such 
stratification could result in improvement in early diagnosis rates and reduction in mortality 
from chronic diseases which are otherwise extremely problematic both in terms of prognosis 
and complications if identified at a late stage(13).   
For alcoholic cirrhosis however there is lack of information on the likely burden of alcohol 
related morbidity that may be present in patients before cirrhosis diagnosis. The morbidities 
believed to be associated with alcohol are many including some malignancies, cardiovascular 
diseases, epilepsy, unintentional and self-harm injuries, and therefore offer the potential for 
stratification on a population level(14). Yet, limited studies have explored the occurrence of 
these morbidities in patients with cirrhosis. We identified one prior small study of 94 people 
with alcoholic liver disease which reported the occurrence of limited categories of 
morbidities (injuries, seizures, oral malignancy and digestive diseases) as a secondary study 
outcome(15) but there was no comparison population in this study and so the significance of 
reported morbidities remains unclear.  
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Given the impact of alcoholic cirrhosis on life expectancy(16) and the potential benefits of 
preventative interventions, there is a clear need to better understand which morbidities may 
be present in patients before the disease is diagnosed. The aim of this study therefore was to 
estimate the burden of diseases that are reported to be at least partly attributable to alcohol in 
patients during the time leading up to a diagnosis of cirrhosis, in comparison with the general 
population. 
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Methods 
Design and data source 
This was a case-control study using primary healthcare data from the Clinical Practice 
Research Datalink (CPRD), a nationally representative database containing electronic 
information on consultations and diagnoses delivered in primary care in the United Kingdom; 
and linked hospital admissions data from the UK’s Hospital Episodes Statistics (HES) 
database. 
Data linkage: Primary care records in CPRD have been linked to secondary care records in 
HES at the individual patient level since 1997; however primary care practices have to give 
consent before the linkage of patient records can be carried out. At the time of this study, 357 
English GP practices that contribute data to CPRD had given consent for linkage to occur. 
The linkage is undertaken by a trusted third party prior to release for research, using patient’s 
unique ID number, date of birth and gender.  Research data are received in fully anonymised 
form.  
Study population 
All adult (>18 years) patients from CPRD-HES linked practices diagnosed with alcoholic 
cirrhosis between 1997 and 2012 were identified. Alcoholic cirrhosis was defined by the 
presence of a recorded diagnostic code for the disease in either primary or secondary care. 
The code lists were adapted and updated from our previously validated definition(17,18). We 
excluded cases with a history of any condition that the differential diagnosis could have been 
alcoholic cirrhosis (e.g. cirrhosis or oesophageal varices of unspecified aetiology), as this 
may have introduced potential misclassification of the diagnosis date. We also ensured that 
cases were at least registered with a practice for up to one year before their first diagnosis 
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record to ensure we included only incident cases.  From the remaining CPRD-HES linked 
patients without a history of cirrhosis or oesophageal varices, we selected 10 control patients 
for each case frequency matched by age (+/- 5 years) and general practice. A date of 
diagnosis, defined as the date for the first record of alcoholic cirrhosis, was assigned to cases. 
Controls were assigned a “pseudo-diagnosis” date which was a randomly generated date 
between 1 year after the start of the linked dataset(1997) up to the date they left the practice 
or died. 
Identifying partly alcohol-attributable morbidity in primary and secondary care  
The conditions considered to be partly attributable to alcohol were based on England’s 
national guide for alcohol-attributable fractions which has been validated against other 
international sources(23,24). These were oral cancers(ICD-10: C00–C14);oesophageal 
cancer(C15);colorectal cancers(C18–C21);breast cancer(C50);diabetes mellitus (E10–E14); 
epilepsy(G40, G41);hypertensive disease(I10–I14);ischaemic heart disease(I20-I25); 
haemorrhagic stroke(I60–I62);ischaemic stroke(I63);road traffic accidents (many V codes); 
falls(W00–W19);drowning(W65–W74);poisonings(X40–X49);other unintentional injuries 
(rest of V codes plus some W, X, Y codes);self-inflicted injuries(X60–X84, Y87.0);violence 
(X85–Y09, Y87.1);and other intentional injuries(Y35).  Read and ICD 10 codes for these 
conditions were used to examine the records of all patients to identify people with these 
diagnoses before cirrhosis diagnosis/pseudo-diagnosis. Where a patient had multiple 
consultations or hospital admissions with a specific diagnostic code, only the first record was 
kept for our analyses. Where codes for different diseases were first entered on the same date - 
for example if an individual received a diagnosis code for hypertension and was also 
diagnosed with diabetes on the same date, both records of unique diseases were included. We 
grouped each first diagnosis into four exposure periods: within 12 months, between 13 
months-2 years, between 3-5 years and between 6-10 years pre-diagnosis or pseudo-
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diagnosis. For clarity of presentation we further grouped all diseases into 
categories(malignant neoplasms, diabetes, diseases of the nervous system, cardiovascular 
diseases, digestive diseases, and injuries) based on ICD10 chapter headings. 
 
Covariates 
We extracted data on patient sex, age, smoking history and alcohol use from CPRD. Age was 
calculated as age at alcoholic cirrhosis diagnosis/pseudo-diagnosis and grouped into five age 
bands. The most recent smoking record before diagnosis/pseudo-diagnosis was used to 
classify individuals as non-smoker, smoker or ex-smoker. The highest level of recorded 
alcohol use was used to classify individuals as never, moderate or harmful or hazardous 
drinker.  Patients with an alcohol record that did not specify consumption frequency and 
volume e.g. “beer drinker”, “wine drinker” were assigned as having an “unclear” alcohol 
consumption status. Missing data on smoking or alcohol use was addressed by including a 
“no recorded data” category so that such patients were not excluded from the analyses. 
 
Statistical analysis 
We calculated the proportion of patients ever diagnosed with any alcohol-attributable 
condition listed above. Logistic regression was used to explore the association between each 
ICD category and alcoholic cirrhosis. We tested for effect modification by age and sex via 
stratified analyses and the fitting of interaction terms in our logistic regression model; the 
significance of models was tested using likelihood ratio tests(LRTs), with p<0.05 considered 
significant. 
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To investigate whether the occurrence of each condition varied across the pre-diagnosis 
period, frequencies and odds ratios were recalculated for each condition for the four pre-
defined pre-diagnosis exposure periods. Not all patients were included in this analysis. We 
applied restriction based on completeness of follow up such that the analyses for any time 
period were limited to those with complete follow up. For example, only patients with a 
minimum of 2 years’ worth of pre-diagnosis data were included in 13 months-2 year time 
period analyses and only those with up to 5 years’ worth of data were included in the 3-5 year 
period. Additional analysis was carried out on injuries to take into account that injuries are 
acute and therefore people could have multiple acute injuries over time. For this analysis, we 
considered whether a patient had had any new injury in each time period rather than just in 
the period of their first injury and reassessed frequencies and odds ratios using this additional 
information.  
All analyses were conducted using the statistical software Stata v12.0 (StataCorp, Texas). 
Ethics statement 
Ethical approval for this study was granted from the Independent Scientific Advisory 
Committee of the CPRD (15_073R). 
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Results 
A total of 2,479 cases and 24,790 controls were included in the study. The mean age at 
cirrhosis diagnosis was 55.6 years. The median observation time prior to diagnosis/pseudo 
diagnosis was higher in cases than controls: 5.7 years(IQR 3.0-9.2 years) and 4.6 years(IQR 
2.4–7.9 years) respectively. Compared with controls, cases were more likely to be men, 
current smokers and harmful/hazardous drinkers (Table 1). 
As shown in table 2, nearly two-thirds (58%) of cases had presented with at least one 
condition partially attributable to alcohol during a preceding primary care or hospital visit, 
compared to 29% in the control population. Compared to the control population, we found a 
stronger risk of alcoholic cirrhosis in those cases with three or more morbidities(OR 9.3,95% 
CI [7.5-11.7]) than in those with one morbidity(OR 2.7,95%CI[2.5-3.0]). When we compared 
cirrhosis risks across age groups, we found stronger associations with cirrhosis for younger 
patients(OR for those <45 years 6.1, 95% CI[4.9-7.5]) who had presented with an attributable 
morbidity compared to older patients(OR for those >75years 2.5, 95%CI[1.7-3.7]). 
Comparing risks by sex, no substantial difference was observed between men and women. 
Table 3 shows age stratified proportions and ORs for each disease group. The most common 
conditions among cases were injuries(35.9%), cardiovascular diseases(23.2%) and diabetes 
(12.8) corresponding to adjusted odds ratios of 4.0(95%CI[3.7-4.4]), 1.6 (95%CI[1.5-1.8]) 
and 2.5 (95%CI[2.2-2.9]) (Table 3). Digestive(6.1%) and nervous system(5.0%) diseases 
were relatively uncommon but had the highest odds ratios when comparing cases to controls 
at 5.4(95%CI[4.4-6.7]) and 4.4(95%CI[3.5-5.5]) respectively. We observed a marked 
variation in the magnitude of effect across age groups for most diseases.  The odds of 
cardiovascular, nervous system, digestive diseases and injuries for instance generally 
decreased with increasing age, with the highest odds among those aged less than 45 years old. 
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For malignant neoplasms and diabetes, odds were highest for those less than 45 years and for 
those over 75 years compared to the other age groups.   
When proportions were calculated for the individual conditions within each ICD 10 category 
(Table 4), we observed that within each category, certain conditions were more strongly 
associated with subsequent diagnosis of alcoholic cirrhosis than others. For example, within 
the cardiovascular disease category, cardiac arrhythmias had the strongest association with 
alcoholic cirrhosis (Adjusted OR 4.2,95% CI[3.3-5.6]) compared to hypertension(adjusted 
OR 1.5, 95%CI[1.3-1.7]) or cerebrovascular diseases (adjusted OR 1.8,95% CI[1.4-2.3]). 
Among injuries, intentional injuries and self-harm (Adjusted OR 6.6, 95%CI[5.4-7.9]) were 
more strongly associated with subsequent diagnosis with alcoholic cirrhosis than 
unintentional injuries(OR 3.7, 95% CI [3.4-4.1]) (Table 4). 
Table 5 shows proportions and ORs for assessed conditions at different time periods. There 
were variations in the odds of the various conditions over time with some conditions 
increasing and others decreasing.  Digestive diseases and diabetes were more likely to occur 
around cirrhosis diagnosis than at other times.  ORs for cardiovascular diseases did not 
change markedly throughout the entire 10 year window but were slightly higher in the 6-10 
year period than in earlier periods. Epilepsy and intentional injuries had relatively high ORs 
which persisted strongly throughout the entire 10 year period assessed. Reanalysing injuries 
showed a stronger association between both intentional and unintentional injuries and 
alcoholic cirrhosis particularly in the 3-5year time periods but did not markedly change the 
overall time-specific patterns. 
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Discussion 
We have found that compared with patients in the general population, those patients who 
acquire a diagnosis of alcoholic cirrhosis attend both primary and secondary health care 
providers more frequently with other conditions reported to be attributable to alcohol as far 
back as 10 years before the diagnosis of alcoholic cirrhosis.  The conditions with the highest 
frequency in cases were injuries(unintentional), cardiovascular diseases (hypertension in 
particular), and diabetes. However, these did not appear to be particularly specific to 
alcoholic cirrhosis as they were also reasonably prevalent among the control population. 
Digestive diseases, intentional injuries and epilepsy which were relatively uncommon among 
cases, appeared to be more strongly associated with alcoholic cirrhosis. It could therefore be 
argued that while targeting individuals with any alcohol-attributable disease may be 
beneficial, focussing on those who present with any of these three conditions (digestive 
diseases, intentional injuries and epilepsy) may be a more sensitive way of identifying people 
who will be more likely to develop alcoholic cirrhosis of the liver later on.  
The main strengths of our study are its large study size and that the morbidities we have 
assessed were prospectively recorded in routinely collected data before the diagnosis of 
alcoholic cirrhosis, thus avoiding recall bias. We frequency-matched cases and controls on 
general practice and age to account for differences in data recording between practices and 
differences in healthcare seeking behaviour between age groups respectively,  but which also 
allowed us to assess interaction by age where it occurred. Data held in CPRD are generally 
representative of the UK population in terms of age, sex and geographical coverage(19). 
However, because HES contains admission information for only English hospitals, CPRD 
patients from Wales, Scotland and Northern Ireland were excluded. Our results are therefore 
expected to be generalizable to the English population at the very least. 
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Some limitations of our study and potential alternative explanations for our findings should 
be noted. First, although we have accounted for age differences in healthcare seeking 
behaviour, there are other potential modifiers of this that we were unable to adjust for e.g. 
socio-economic status, education and family history. We therefore cannot rule out the 
possibility of residual confounding on our estimates. We have intentionally not adjusted our 
estimates for level of alcohol use since alcohol consumption is directly on the causal pathway 
of alcoholic cirrhosis and thus adjustment would be inappropriate. 
The morbidities we have assessed were prospectively recorded in the medical record before 
the diagnosis of alcoholic cirrhosis.  However there is still the possibility of reverse causality, 
particularly in the association between diabetes and cirrhosis that we observed. Several 
studies have shown that metabolic syndrome related to pre-existing diabetes may result in an 
increased predisposition to cirrhosis(20–22). Alternatively, it has also been implied that 
impaired glucose metabolism in cirrhosis can lead to diabetes(23–25). Since, as with all 
epidemiological studies of chronic diseases with long subclinical periods (i.e. both diabetes 
and cirrhosis), we are only able identify the date of acquisition of cirrhosis (or diabetes) 
diagnosis rather than the date of biological onset, it becomes difficult to definitively establish 
the temporal association of the relationship. 
 The exceptionally high risk of digestive diseases and diabetes we found within the year of 
cirrhosis diagnosis compared to other later periods may reflect another potential problem, 
namely ascertainment bias. This may occur during gastro-intestinal based work-up for 
cirrhosis diagnosis where clinical suspicion of liver disease was high in the year prior to 
diagnosis of alcoholic cirrhosis.  However, it could also be argued that perhaps the presence 
of other digestive diseases may have led to quicker diagnosis of alcoholic cirrhosis, since 
those with these morbidities would have been more likely to utilise healthcare services 
leading to increased opportunities to identify cirrhosis. 
15 
 
Finally, we have shown a higher risk of several malignancies (oropharynx, oesophageal and 
laryngeal cancers) among people with alcoholic cirrhosis. A common factor that is also 
strongly associated with these malignancies is cigarette smoking(26,27). Since nearly half of 
the cases included in our study were identified as smokers, it is likely that the higher risk of 
laryngeal and oesophageal cancer we have found may well be related more importantly to 
smoking and only partly to alcohol.  Though we have adjusted for most recent documented 
smoking status this is probably an imperfect measurement of true lifetime smoking habit (e.g. 
we are unable to adjust for pack-years as this level of detail is not available in our data) and 
there will likely be residual confounding by smoking in operation in our adjusted effect 
estimates. 
 
Previous literature 
There are limited studies published on healthcare use and morbidities in people with 
alcoholic cirrhosis with which we can compare our study. Verrill et al (2006) retrospectively 
reviewed hospitalised patients with alcoholic cirrhosis in Southampton, UK between 1995 
and 2000 to identify how often patients had made contact with primary or secondary care in 
the five year period before they received a diagnosis of alcoholic cirrhosis. Similar to our 
findings, they report that patients had presented with injuries, seizures, oral cancers and 
digestive diseases during the period before alcoholic cirrhosis was diagnosed(15). However, 
the inclusion of only hospitalised patients who may not be representative of the entire 
population of people with alcoholic cirrhosis and the absence of any control population make 
it difficult to directly compare this study with ours.  In a second study in Scotland UK where 
high healthcare utilisation of patients with alcohol use disorders including alcoholic liver 
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disease has been shown, morbidities that patients presented with before the disease were not  
reported(28).  
Conclusion and implications 
We believe that the partly alcohol-attributable diseases that patients consult for can be useful 
as an indication of potential development of alcoholic cirrhosis. We therefore think that 
physicians could combine the early warning signs of these partially alcohol-attributable 
diseases and injuries with other important prognostic information to increase their assessment 
of alcohol misuse in individuals.  Particular attention should also be paid to those diagnosed 
with more than one partially alcohol attributable morbidity as the likelihood of a subsequent 
diagnosis of alcoholic cirrhosis was 9-fold higher for patients with three or more of these 
identified morbidities. The stronger associations found between all diseases and cirrhosis for 
those less than 45 years of age suggests that the potential advantage of risk stratification 
using alcohol-attributable health care attendances may be even greater in this age group. 
In conclusion, we have shown that among most of the patients diagnosed with alcoholic 
cirrhosis, prior primary or secondary care diagnoses for conditions known to be attributable 
to alcohol are common. These findings suggest that practitioners may be able to identify 
those who may later develop alcoholic cirrhosis of the liver by reviewing people presenting 
with partially alcohol-attributable conditions more closely.  We believe that if these high risk 
groups of patients can be screened for alcohol misuse, and treated appropriately, practitioners 
may be able to help reduce or avoid the long term consequences of development of alcoholic 
liver disease. 
  
17 
 
References 
1.  Rehm J,Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. 
Journal of  Hepatology 2013;59:160-8 
2.  Williams R,Aspinall R, Bellis M,Camps-Walsh G, Cramp M,Dhawan A, et al. 
Addressing liver disease in the UK: a blueprint for attaining excellence in health care 
and reducing premature mortality from lifestyle issues of excess consumption of 
alcohol, obesity, and viral hepatitis. The Lancet. 2014; 384(9958):1953–97.  
3.  Kamper-Jørgensen M, Grønbæk M, Tolstrup J, Becker U. Alcohol and cirrhosis: dose–
response or threshold effect? Journal of Hepatology. 2004; 41(1):25–30.  
4.  Becker U, Deis A,Sorensen TI,Gronbaek M,Borch-Johnsen K,Muller CF, et al. 
Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective 
population study. Journal of Hepatology. 1996;23(5):1025–9.  
5.  Verrill C, Markham H,Templeton A,Carr NJ,Sheron N. Alcohol-related cirrhosis—early 
abstinence is a key factor in prognosis, even in the most severe cases. Addiction. 
2009;104(5):768–74.  
6.  Huang Y-W,Yang S-S,Kao J-H. Pathogenesis and management of alcoholic liver 
cirrhosis: a review. Hepatic Med Evid Res. 2011;3:1–11.  
7.  Bellentani S,Saccoccio G,Costa G,Tiribelli C,Manenti F,Sodde M, et al. Drinking habits 
as cofactors of risk for alcohol induced liver damage. Gut. 1997;41(6):845–50.  
8.  Hubbard RB,Baldwin DR. Diagnosing lung cancer earlier in the UK. Thorax. 2010 
;65(9):756–8.  
9.  Corner J,Hopkinson J,Fitzsimmons D,Barclay S,Muers M. Is late diagnosis of lung 
cancer inevitable? Interview study of patients’ recollections of symptoms before 
diagnosis. Thorax. 2005;60(4):314–9.  
10.  Hamilton W. Cancer diagnosis in primary care. British Journal of General Practice. 
2010;60(571):121–8.  
11.  Georghiou T,Steventon A,Billings J,Blunt I,Lewis G,Bardsley M. Predictive risk and 
health care: an overview. [Internet]. London: Nuffield Trust, 2011; Available from: 
http://www.nuffieldtrust.org.uk/publications/predictive-risk-and-health-care-overview 
12.  Dixon J,Bardsley M.Predictive risk modelling using routine data: underexploited 
potential to benefit patients. J Health Serv Res Policy. 2012;17(3):131–2.  
13.  NHS-Leeds North Clinical Commissioning Group. Risk Stratification (Pro-Active Care 
Management). 2015. NHS 2015 
14.  Rehm J,Baliunas D,Borges GLG,Graham K, Irving H, Kehoe T, et al. The relation 
between different dimensions of alcohol consumption and burden of disease: an 
overview. Addiction. 2010;105(5):817–43.  
18 
 
15.  Verrill C,Smith S,Sheron N. Are the opportunities to prevent alcohol related liver deaths 
in the UK in primary or secondary care? A retrospective clinical review and prospective 
interview study. Subst Abuse Treat, Prev Policy. 2006;1(1):1–5.  
16.  Ratib S,Fleming KM,Crooks CJ,Aithal GP,West J. 1 and 5 year survival estimates for 
people with cirrhosis of the liver in England, 1998-2009: a large population study. 
Journal of Hepatology. 2014;60(2):282–9.  
17.  Ratib S,West J,Crooks CJ,Fleming KM. Diagnosis of Liver Cirrhosis in England, a 
Cohort Study, 1998-2009: A Comparison with Cancer. American Journal of 
Gastroenterology. 2014;109(2):190–8.  
18.  Fleming KM,Aithal GP,Solaymani-Dodaran M,Card TR,West J. Incidence and 
prevalence of cirrhosis in the United Kingdom, 1992–2001: A general population-based 
study. Journal of Hepatology. 11;49(5):732–8.  
19.  Crooks CJ. Epidemiology of upper gastrointestinal bleeding. Ph.D. Thesis. University 
Of Nottingham: UK; 2013.  
20.  Adams LA,Sanderson S,Lindor KD,Angulo P. The histological course of nonalcoholic 
fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. 
Journal of  Hepatology. 2005;42(1):132–8.  
21.  Angulo P, Keach JC,Batts KP,Lindor KD.Independent predictors of liver fibrosis in 
patients with nonalcoholic steatohepatitis.Hepatology.1999;30(6):1356–62.  
22.  Hickman IJ,Macdonald GA. Impact of Diabetes on the Severity of Liver Disease. 
American Journal of Medicine. 2007;120(10):829–34.  
23.  Petrides AS. Hepatogenic diabetes: pathophysiology, therapeutic options and prognosis. 
Z Gastroenterol. 1999 ;Suppl 1:15–21.  
24.  Deschenes M,Somberg KA. Effect of transjugular intrahepatic portosystemic shunt 
(TIPS) on glycemic control in cirrhotic patients with diabetes mellitus. American 
Journal of Gastroenterology. 1998;93(3)483.  
25.  Picardi A,D’Avola D,Gentilucci UV,Galati G, Fiori E, Spataro S, et al. Diabetes in 
chronic liver disease: from old concepts to new evidence. Diabetes Metab Res Rev. 
2006;22(4):274–83.  
26.  Gandini S,Botteri E,Iodice S,Boniol M,Lowenfels AB,Maisonneuve P, et al. Tobacco 
smoking and cancer: a meta-analysis. International Journal of Cancer. 2008 
;122(1):155–64.  
27.  Dossus L,Boutron-Ruault M-C,Kaaks R,Gram IT,Vilier A,Fervers B, et al. Active and 
passive cigarette smoking and breast cancer risk: results from the EPIC cohort. 
International Journal of Cancer. 2014;134(8):1871–88.  
28.  Morris M,Johnson D,Morrison DS. Opportunities for prevention of alcohol-related 
death in primary care: results from a population-based cross-sectional study. Alcohol 
2012;46(7):703–7.  
19 
 
 
Table 1: Study population characteristics.  
 
 Cases 
n=2,479 
Controls 
n=24,790 
P-value 
Age at diagnosis(years)    
Mean(SD) 55.6(11.7) 55.4(12.4)  
Age group (n, %)    
min-44 419(16.9) 5,024(20.3)  
45-54 750(30.3) 6,772 (27.3)  
55-64 753(30.4) 7,222 (29.1)  
65-74 403(16.3) 4,027 (16.2)  
 ≥ 75 154(6.2) 1,742 (7.0)  
Observation time(years)    
Median(IQR) 5.7(3.0 – 9.2) 4.6(2.4 – 7.9)  
   Up to 12months 2,479(100.0) 24,790 (100.0)  
   Up to 2years 2,151(86.8) 20,162 (81.3)  
   Up to 5years 1,377(55.6) 11,422(46.1)  
   Up to 10 years   482 (19.4) 3,432(13.8)  
Sex (n, %)   <0.001 
Male 1,660(67.0) 12,453(50.2)  
Female     819(33.0) 12,337(49.8)  
    
Smoking status   <0.001 
Non smoker 508(20.5) 9,995(40.3)  
Current smoker 1,175(47.4) 5,080(20.5)  
Ex-smoker 415(16.7) 4,543(18.3)  
No record available 381(15.4) 5,172(20.9)  
Alcohol use status   <0.001 
Data available  2,088(84.2 )  16,752( 67.6)  
    Never 48(1.9) 2,347(9.5)  
    moderate 377(15.2) 11,374(45.9)  
    Hazardous/harmful 1,507( 60.7) 2,344(9.5)  
    unclear 156( 6.3) 687(2.8)  
No record available 391(15.8) 8,038(32.4)  
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Table 2: Number, proportion and odds ratios describing the likelihood of presenting with at 
least one partially alcohol-attributable condition at any point during the study 
 Cases                        
(n= 2,479) 
Controls                    
 (n = 24,790) 
OR(95% CI) 
Prior diagnosis of an alcohol-attributable condition 
Ever  1,443(58.2) 7,201(29.1) 3.3(3.1-3.7) 
    1     909(36.7)    5,627(22.7) 2.7(2.5-3.0) 
    2     407(16.4)    1,343(5.4) 5.1(4.5-5.8) 
    3 or more conditions     127(5.1)    231(0.9) 9.3(7.5-11.7) 
Never 1,036(41.8) 17,589(70.9) 
 
 
Sex     
Male    
  Ever   970(58.4) 3,525(28.3) 3.6(3.2-3.9) 
  Never  690(41.6) 8,928(71.7) - 
Female    
  Ever  473(57.8) 3,676(29.8) 3.2(2.8-3.7) 
  Never  346(42.3) 8,661(70.2) - 
    
Age groups    
18-44    
  Ever 222(52.9) 782(15.6) 6.1(4.9-7.5) 
  Never 197(47.0) 4,245(84.4) - 
45-54    
  Ever 406(54.1) 5300(78.3) 4.2(3.6-4.9) 
  Never  344(45.9) 1,472(21.7) - 
55-64    
  Ever  432(57.4) 2,347(32.5) 2.8(2.4-3.3) 
  Never 321(42.6) 4,875(67.5) - 
65-74    
  Ever  270(67.0) 1,693(42.1) 2.8(2.2-3.5) 
  Never 133(33.0) 2,334(57.9) - 
 ≥ 75    
  Ever  113(73.4) 907(52.1) 2.5(1.7-3.7) 
  Never 41(26.6) 835(47.9) - 
    
 
*percentages are calculated as a fraction of those with alcohol attributable conditions, cases n=1,443 and 
controls n=7,201. 
Lrtest P value for sex interaction: p=0.26 
Lrtest P value for age interaction: p < 0.0001 
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Table 3: Overall and age stratified proportions and odds ratios for selected 
comorbidities( classified by ICD-10 headings)  for cases and controls 
 
 
 Cases 
(n=2,479) 
n(%) 
Controls     
(n=24,790) 
n(%) 
                  OR (95% CI)  
LRT p-
value for 
age 
interaction  
Unadjusted  Adjusted* 
Malignant neoplasms 62(2.5) 323(1.3) 1.9(1.5-2.6) 2.4(1.8-3.3) 0.61 
18-44 4(0.9) 13(0.3) 3.7(1.2-11.5) 4.3(1.3-14.3)  
45-54 8(1.1) 47(0.7) 1.5(0.7-3.2) 1.8(0.8-4.0)  
55-64 21(2.8) 112(1.6) 1.8(1.1-2.9) 2.4(1.5-3.9)  
65-74 17(4.2) 102(2.5) 1.7(1.0-2.9) 2.0(1.2-3.5)  
 ≥ 75 12(7.8) 49(2.8) 2.9(1.5-5.6) 3.3(1.6-6.5)  
Diabetes 318(12.8) 1,303(5.3) 2.7(2.3-2.9) 2.5(2.2-2.9) 0.02 
18-44 21(5.0) 65(1.3) 4.0(2.4-6.7) 4.0(2.3-6.8)  
45-54 62(8.3) 234(3.5) 2.5(1.9-3.4) 2.3(1.7-3.2)  
55-64 109(14.5) 445(6.2) 2.6(2.1-3.2) 2.4(1.9-3.1)  
65-74 75(18.6) 383(9.5) 2.2(1.7-2.9) 2.0(1.5-2.7)  
 ≥ 75 51(33.1) 176(10.1) 4.4(3.0-6.4) 4.2(2.8-6.3)  
Nervous system 
diseases 
125(5.0) 264(1.1) 4.9(3.9-6.1) 4.4(3.5-5.5) 0.0001 
18-44 43(10.3) 53(1.1) 10.7(7.1-16.3) 9.1(5.8-14.3)  
45-54 45(6.0) 72(1.0)  5.9(4.1-8.7) 5.1(3.4-7.7)  
55-64 27(3.6) 82(1.1)  3.2(2.1-5.0) 3.2(2.0-5.0)  
65-74 9(2.2) 33(0.8)  2.8(1.3-5.8) 2.2(1.0-4.7)  
 ≥ 75 1(0.7) 24(1.4)  0.5(0.1-3.4) 0.5(0.1-3.5)  
Cardiovascular 
diseases 
576(23.2) 3,877(15.6) 1.6(1.5 -1.8) 1.6(1.5-1.8) 0.0002 
18-44 36(8.6) 151(3.0) 3.0(2.1-4.4) 3.3(2.2-4.9)  
45-54 133(17.7) 605(8.9) 2.2(1.8-2.7) 2.1(1.7-2.6)  
55-64 194(25.8) 1,353(18.7) 1.5(1.3-1.8) 1.4(1.2-1.7)  
65-74 155(38.5) 1,149(28.5) 1.6(1.3-1.9) 1.5(1.2-1.8)  
 ≥ 75 58(37.7) 619(35.5) 1.1(0.8-1.5) 1.1(0.7-1.5)  
Digestive diseases 152(6.1) 298(1.2) 5.4(4.3-6.5) 5.4(4.4-6.7) <0.0001 
18-44 36(8.6) 27(0.5) 17.4(10.4-28.9) 21.1(12.1-36.7)  
45-54 35(4.7) 62(0.9) 5.3(3.5-8.1) 5.1(3.2-8.1)  
55-64 41(5.4) 101(1.4) 4.1(2.8-5.9) 4.1(2.7-6.0)  
65-74 29(7.2) 76(1.9) 4.0(2.6-6.3) 4.1(2.6-6.5)  
 ≥ 75 11(7.1) 32(1.8) 4.1(2.0-8.3) 3.7(1.7-7.7)  
Injuries 891(35.9) 2,962(11.9) 4.1(3.8-4.5) 4.0(3.7-4.4) 0.008 
18-44 172(41.1) 554(11.0) 5.6(4.5-7.0) 4.9(3.9-6.1)  
45-54 270(36.0) 720(10.6) 4.7(4.0-5.6) 4.3(3.5-5.1)  
55-64 237(31.5) 835(11.6) 3.5(3.0-4.2) 3.5(2.9-4.2)  
65-74 149(36.9) 500(12.4) 4.1(3.3-5.2) 4.3(3.4-5.4)  
 ≥ 75 63(40.9) 353(20.3) 2.7(1.9-3.8) 3.2(2.2-4.6)  
*adjustment for sex and smoking status   
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Table 4: Proportions and ORs for all morbidities for cases and controls 
 
aadjustment for age, sex and smoking status   bexcludes gestational diabetes       cUnintentional injuries include falls, fractures, 
asphyxia, road traffic accidents and unintentional poisonings. 
dIntentional injuries include assault, intentional self-harm and intentional poisoning   
Conditions Cases 
(n=2479) 
Controls 
(n=24,790) 
                    OR (95%CI) 
    
Unadjusted      Adjusteda 
Malignant neoplasms of:     
larynx 5(0.2) 6(0.02) 8.3(2.5-27.4) 6.8(1.9-23.5) 
Colon and rectum 11(0.4) 82(0.3) 1.3(0.7-2.5) 1.3(0.7-2.5) 
Breast 12(0.48) 212(0.9) 0.6(0.3-1.0) 0.9(0.5-1.6) 
Oesophagus 4(0.2) 12(0.1) 3.3(1.1 -10.4) 3.5(1.1-11.3) 
Lip, oral cavity and pharynx 7(0.3) 18(0.1) 3.9(1.6-9.3) 2.6(1.0-6.4) 
Diabetesb 318(12.8) 1,303(5.3) 2.6(2.3-3.0) 2.6(2.2-2.9) 
     
Diseases of the nervous system 
Epilepsy and Status epilepticus 125(5.0) 264(1.1) 4.9(3.9-6.1) 4.4(3.5-5.5) 
Cardiovascular diseases     
Cardiac arrhythmias  84(3.4) 220(0.9) 3.9(3.0-5.1) 4.2(3.3-5.6) 
Cerebrovascular diseases 96(3.8) 468(1.9) 2.1(1.7-2.6) 1.8(1.4-2.3) 
Hypertensive diseases 359(14.5) 2,605(10.5) 1.4(1.3-1.6) 1.5(1.3-1.7) 
Ischaemic heart disease 160(6.5) 1,161(4.6) 1.4(1.2-1.7) 1.2(0.9-1.4) 
Digestive diseases     
Pancreatitis 83(3.4) 49(0.2) 17.5(12.2-25.0) 15.4(10.6-22.5) 
Cholelithiasis 81(3.3) 271(1.1) 3.1(2.4-3.9) 3.1(2.4-4.1) 
Injuries     
Unintentional injuriesc 790 (31.8) 2,752 (11.1) 3.7(3.4-4.1) 3.7(3.4-4.1) 
Intentional injury/self-harmd 236 (9.5) 319 (1.3) 8.1 (6.8-9.6) 6.5(5.4-7.8) 
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Table 5:  The proportion of patients presenting with each examined condition at different 
periods before cirrhosis diagnosis with OR (95% CI) comparing cases to controls. 
Time to diagnosis At risk       
cases  
n(%) 
At risk 
controls      
n(%) 
OR (95% CI) 
Unadjusted Adjusted* 
Malignant neoplasms     
             0-12months 38 (1.5) 83 (0.3) 4.6(3.1-6.8) 5.1(3.4-7.8) 
            13mths- 2yrs 9(0.4) 61(0.3) 1.4(0.7-2.8) 1.9(0.9-3.9) 
            3-5yrs 11(0.8) 68(0.6) 1.3(0.7-2.5) 1.6(0.8-3.1) 
            6-10yrs - 40(1.2) -  - 
Diabetes     
             0-12months 78 (3.2) 207 (0.8) 3.8(2.9-5.0) 3.9(2.9-5.1) 
            13mths- 2yrs 52 (2.4) 183(0.9) 2.7(1.9-3.7) 2.3(1.7-3.2) 
            3-5yrs 61(4.4) 228(2.0) 2.2(1.7-3.0) 2.1(1.5-2.8) 
            6-10yrs 28(5.9) 109(3.2) 1.9(1.2-2.9) 1.7(1.1-2.6) 
Nervous system diseases     
             0-12months 38(1.5) 39(0.2) 9.9(6.3-15.5) 9.7(6.0-15.7) 
            13mths- 2yrs 13(0.6) 35(0.2) 3.5(1.8-6.6) 2.4(1.2-4.6) 
            3-5yrs 13(0.9) 42(0.4) 2.6(1.4-4.8) 2.4(1.2-4.6) 
            6-10yrs 18(3.7) 22(0.6) 6.0(3.2-11.3) 5.6(2.8-11.0) 
Cardiovascular diseases     
             0-12months 96(3.9) 681(2.8) 1.4(1.1-1.8) 1.4(1.1-1.7) 
            13mths- 2yrs 71(3.3) 559(2.8) 1.2(0.9-1.5) 1.1(0.8-1.4) 
            3-5yrs 125(9.1) 827(7.2) 1.3(1.1-1.5) 1.2(0.9-1.5) 
            6-10yrs 71(14.7) 337(9.8) 1.6(1.2-2.1) 1.4(1.1-1.9) 
Digestive diseases     
             0-12months 68(2.7) 63(0.3) 11.1(7.8-15.7) 11.9(8.3-17.2) 
            13mths- 2yrs 21(0.9) 49(0.2) 4.0(2.4-6.8) 3.3(1.9-5.7) 
            3-5yrs 23(1.7) 67(0.6) 2.9(1.8-4.6) 2.9(1.8-4.9) 
            6-10yrs 8(1.7) 29(0.8) 1.9(0.9-4.3) 1.7(0.8-4.0) 
Unintentional injuries     
             0-12months 198(7.9) 525(2.1) 4.0(3.4-4.8) 3.9(3.2-4.6) 
            13mths- 2yrs 124 (5.8) 418(2.1) 2.9(2.4-3.5) 2.7(2.2-3.3) 
            3-5yrs 148(10.7) 701(6.1) 1.8(1.5-2.2) 1.8(1.5-2.2) 
            6-10yrs 94(19.5) 297(8.7) 2.5(1.9-3.3) 2.6(2.0-3.4) 
Intentional injury/self-harm 
             0-12months 29(1.2) 73(0.3) 4.0(2.6-6.2) 3.0(1.9-4.7) 
            13mths- 2yrs 40(1.9) 53(0.3) 7.2(4.8-10.9) 5.9(3.8-9.0) 
            3-5yrs 50(3.6) 55(0.5) 7.8(5.3-11.5) 6.3(4.2-9.6) 
            6-10yrs 32(6.6) 32(0.9) 7.6(4.6-12.5) 6.8(3.9-11.7) 
     
Numbers at risk within each analyses time period 
0-12months 2,479 (100.0) 24,790 (100.0) 
13months-2years 2,151 (86.8) 20,162 (81.3) 
3-5years 1,377(55.6) 11,422(46.1) 
6-10years 482 (19.4) 3,432(13.8) 
*Adjustment for age, sex and smoking status    
- number within cell <5 
 
 
